Bentley Up on FDA Approval of Generic Zocor
by H.S. Ayoub
BioHealthInvestor.com
Shares of Bentley Pharmaceuticals (BNT) are up more than 13% early Friday as the company announced that its U.S. marketing partner, Perrigo Company, has received marketing approval for simvastatin 5 mg, 10 mg, 20 mg, 40 mg and 80 mg tablets.
The FDA also determined that these formulations are equivalent to Merck's (MRK) Zocor. Simvastatin will be manufactured at Bentley's Facility in Spain.
The company has already initiated the manufacturing process for fast introduction into the U.S. market.
Shares of Bentley were trading abover $11 at one point during morning trading hours.
The company's total stock worth is just under $250 million. Bentley holds cash of just over $20 million with a debt of $380 thousand as last reported on Yahoo!Finance.
Annual sales and net profit have been increasing substantially over the last few years.
On November 9 a company director purchased almost $50 thousand worth of stock at $9.85 a share.
__________
Related BHI articles:
- Weak U.S. Dollar Good for Biotechs!
- Bentley Pharmaceuticals Revs Up Production Efforts With Cardinal Health
__________
BioHealthInvestor.com
Shares of Bentley Pharmaceuticals (BNT) are up more than 13% early Friday as the company announced that its U.S. marketing partner, Perrigo Company, has received marketing approval for simvastatin 5 mg, 10 mg, 20 mg, 40 mg and 80 mg tablets. The FDA also determined that these formulations are equivalent to Merck's (MRK) Zocor. Simvastatin will be manufactured at Bentley's Facility in Spain.
The company has already initiated the manufacturing process for fast introduction into the U.S. market.
Shares of Bentley were trading abover $11 at one point during morning trading hours.
The company's total stock worth is just under $250 million. Bentley holds cash of just over $20 million with a debt of $380 thousand as last reported on Yahoo!Finance.
Annual sales and net profit have been increasing substantially over the last few years.
On November 9 a company director purchased almost $50 thousand worth of stock at $9.85 a share.
__________
Related BHI articles:
- Weak U.S. Dollar Good for Biotechs!
- Bentley Pharmaceuticals Revs Up Production Efforts With Cardinal Health
__________
posted by Nico at
10:01 AM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home